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Antigen-induced airway inflammation and
hyper-responsiveness does not enhance airway
responses to a subsequent antigen challenge in rats
S. LABERGE, P. ROSSI, X. X. YANG AND J. G. MARTIN
Meakins-Christie Laboratories, Royal Victoria Hospital, McGill University and the Respiratory Health Network
of Centres of Excellence, Montreal, Quebec, Canada
Brown–Norway (BN) rats develop airway hyper-responsiveness and lung eosinophilia 18–24 h after ovalbumin
(OA) challenge. We hypothesized therefore that allergen-induced airway inflammation would further enhance
airway responses to a subsequent antigen challenge. Animals were sensitized to both OA and bovine serum albumin
(BSA) and, 14 days later, challenged by aerosols with both antigens 24 h apart. Measurements of pulmonary
resistance (RL) were made for 8 h after the second antigen challenge and bronchoalveolar lavage (BAL) was
performed. Animals were divided into three groups and received two challenges as follows: saline-BSA (n9), OA-
saline (n8) and OA-BSA (n10). Sensitization was confirmed by measurements of specific OA-IgE and BSA-IgE.
Early responses [determined as the highest value of RL within the first 30 min after the challenge] were absent in all
study groups. The late responses [determined from the area under the RL versus time curve from 120 to 480 min
after the challenge] were significantly greater in animals challenged with BSA (1516+386) compared to saline
(376+409; P5005). However previous exposure to OA did not further increase the late response in animals
subsequently challenged with BSA (2011+367) despite enhanced airway responsiveness to LTD4 at this time
point. BAL eosinophils and lymphocytes were significantly increased following BSA challenge in previously OA-
challenged animals, compared to numbers retrieved from animals previously exposed to saline (P5005). These
data indicate that previous exposure to OA did not further increase the LR to a second antigen challenge despite
substantial increases in airway inflammatory cells and airway hyper-responsiveness to LTD4.
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The allergic response to an inhaled antigen is characterized
by an acute phase of airway obstruction that occurs within
minutes after the challenge and resolves in 1–2 h. In a
proportion of individuals this immediate phase of the
allergic reaction is followed by a more prolonged phase of
airway obstruction which begins 3–4 h after allergen
exposure and may persist for 12–24 h (1–3). This late
asthmatic response (LR) has received much attention
because of its association with bronchial hyper-responsive-
ness (4,5) and airway inflammation (6,7), two cardinal
features of chronic asthma. Some investigators have
hypothesized that antigen-induced airway inflammation
favors the persistence of asthmatic symptoms. Indeed, the
chronic inflammation of asthma could conceivably be an
expression of the LR to aeroallergens. The LR mayReceived 17 September 1999 and accepted in revised form 30
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0954-6111/00/010044+07 $35?00/0perpetuate the asthmatic process by inducing hyper-
responsiveness and by amplifying the bronchial response
to subsequent exposures to antigens (8). Conversely,
avoidance of allergen exposure may improve lung function
and asthma symptoms (9).
Numerous studies have provided compelling evidence
that inflammatory cells, including eosinophils and lympho-
cytes, recovered from the airways following antigen
challenge, are in a heightened state of activation (10–12).
The number of activated eosinophils infiltrating the
bronchial mucosa (13,14) and recovered in the bronchoal-
veolar lavage (15) correlates with disease severity. Because
these inflammatory cells are capable of releasing an array of
mediators and chemotactic factors that may either directly
or indirectly alter airway function, the presence of antigen-
induced airway inflammation may favor larger and more
sustained responses to subsequent allergen exposure.
Despite this theoretical possibility, the majority of studies
in the literature have focused on the eects of single antigen
exposure on the airway responses. The present study was
undertaken in order to delineate the eects of pre-existing
airway inflammation on the pattern of allergen-induced
bronchoconstriction. More specifically we examined the
eects of antigen-induced airway inflammation and airway# 2000 HARCOURT PUBLISHERS LTD
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early and late allergic responses, as well as on the airway
inflammation following a subsequent antigen exposure in
the rat. We used the highly inbred Brown–Norway (BN)
rats which develop these airway responses in high
prevalence after antigen challenge (16). Following ovalbu-
min (OA) challenge, sensitized BN rats develop an early
response (ER) followed by a LR. The inflammatory
reaction is characterized by an accumulation of neutrophils
within the lung tissues 8 h after the challenge (17). Airway
hyper-responsiveness to inhaled methacholine appears
concomitantly with an influx of eosinophils in the airways
by 24–32 h after the challenge (18,19). Therefore we
anticipated that pre-existing OA-induced airway inflamma-
tion would be associated with hyper-responsiveness to
mediators of the ER and LR. In order to verify this
hypothesis we performed two allergen challenges 24 h
apart. In order to circumvent the potential induction of
immune tolerance or depletion of local specific IgE
associated with repeated exposures to the same antigen,
animals were sensitized to two unrelated antigens and
subsequently exposed to the two antigens in sequential
manner.
Methods
ANIMALS AND SENSITIZATION
Thirty-eight male BN rats, 6–8 weeks old, were obtained
from a commercial source (Charles River, St-Constant,
Canada) and housed in a conventional animal facility at
McGill University (Montreal, Canada). All animals were
actively sensitized with a subcutaneous injection of 1 mg
ovalbumin (OA) and 1 mg bovine albumin (BSA) (Sigma
Chemical Co, St-Louis, MO, U.S.A.) precipitated in 348
aluminum hydroxide gel (BDH Chemicals LTD, Poole,
England) in 1 ml of saline 09% (wt/vol). Bordetella
pertussis vaccine (Institut Armand Frappier, Montreal,
Quebec, Canada), 05 ml containing 1010 heat-killed bacilli,
was injected intraperitoneally at the same time as a
adjuvant to all rats.
STUDY PROTOCOL
On day 14 post-sensitization, blood was obtained for OA-
specific and BSA-specific IgE measurements. Animals were
then challenged by aerosol with the first antigen and were
allowed to recover. Twenty-four hours later, animals were
exposed to the second antigen and lung resistance (RL) was
then recorded for 8 h. Subsequently, the lung inflammatory
response was assessed by bronchoalveolar lavage (BAL).
Animals were divided into three study groups. Eight
animals were first challenged with OA and subsequently
with saline (OA-saline group). Nine animals were first
challenged to saline and secondly to BSA (saline-BSA
group). Ten animals were exposed to OA and then to BSA
(OA-BSA group).
To confirm the development of allergen-induced airway
hyper-responsiveness following OA exposure in sensitizedanimals using the present sensitization protocol, an
additional group of sensitized rats underwent measurement
of airway responsiveness to LTD4 24 h after saline (n4) or
OA (n7) exposure.
ANTIGEN CHALLENGE
Animals were anesthetized with xylazine (7 mg kg71)
(Chemagro Limited, Etobicoke, Ontario, Canada) and
pentobarbital (50 mg kg71) (MTC Pharmaceuticals, Cam-
bridge, Ontario, Canada), intraperitoneally for the first
antigen challenge and with urethane (11 g kg71) intrape-
ritoneally for the second antigen challenge. Blind endo-
tracheal intubation with a 6 cm length PE-240 polyethylene
tubing was performed. Intubated animals were connected
to a small plexiglass box (265 ml in volume) and aerosolized
with either saline, OA (5% wt/vol in saline) or BSA (5% wt
vol in saline) for 5 min. Aerosols were generated using a
Hudson nebulizer (model 1400, Hudson Inc, Temecula,
CA, U.S.A.) with an output of 025 ml min71 connected to
one side port of the box.
MEASUREMENTS OF AIRWAY RESPONSES
TO ANTIGEN
Measurements of airway responses to the second antigen
challenge were performed as previously described (16).
Briefly, anesthetized and intubated animals were placed on
a heating pad and rectal temperature was monitored
continuously to maintain body temperature constant
throughout the experiment. Animals were kept in the
lateral decubitus position and alternated between left and
right sided hourly. The end of the endotracheal tube was
connected to the plexiglass box. Airflow was measured by
a pneumotachograph (Fleisch 00, Bionetics, Montreal,
Canada) coupled to a dierential pressure transducer (PX
170-14 DV, Omega Engineering, Stamford, CT, U.S.A.)
connected to the other side port of the box. A water filled
esophageal catheter attached to a pressure transducer
(Transpac II, Sorensen, Abbott, IL, U.S.A.) was used to
determine changes in pleural pressure. From flow, volume
and transpulmonary pressure, RL was calculated by fitting
the equation of motion of the lung to the data by multiple
linear regression analysis (20) using a commercial software
package (RHT infoDat Inc, Montreal, Canada).
Measurements of RL were taken at baseline, immediately
after antigen inhalation, 5, 10, 15, 20 and 30 min after
challenge, and then subsequently at 15-min intervals for a
period of 8 h. The box was flushed with fresh air between
measurements to prevent accumulation of carbon dioxide.
MEASUREMENT OF AIRWAY RESPONSES
TO LTD4
Airway responsiveness to inhaled LTD4 was assessed 24 h
after saline or OA challenge in anesthetized and incubated
animals. Measurements of changes in RL induced by
tracheal instillation of saline or saline containing increasing
46 S. LABERGE ET AL.amounts of LTD4 (05, 50, 500, 5000 ng) were made.
Lung resistance was measured four times at 1 min intervals
after each dose of agonist, and the maximal response, which
usually occurred after 1 min, was recorded. After RL
returned to close to the baseline value, the next dose of
LTD4 was administered. Cumulative concentration-
response curves were constructed.
BRONCHOALVEOLAR LAVAGE
At the end of the experiment, the lungs were lavaged by
instillation of 25 ml of saline at room temperature Saline
was instilled in 5 ml aliquots and gently aspirated through
the endotracheal tube. Total cells counts were determined
on a fresh specimen using a hemacytometer. Dierential
counts, based on standard morphologic criteria, were
assessed from cytocentrifuged preparations (Cytospin II,
Shandon, Cheshire, England) on a May–Gru¨nwald and
Giemsa Stain; 200 cells were counted under oil immersion
microscopy.
IMMUNOGLOBULIN MEASUREMENTS
Blood was collected by orbital bleeding 14 days after
sensitization and prior to the first antigen challenge. Serum
was obtained by centrifugation and kept frozen at 7208
until use. Specific IgE to OA and BSA were determined by
ELISA as previously described (21). Plates (Immulon 2,
Dynatech Laboratories, Chantilly, VA, U.S.A.) were
coated overnight at 48C with mouse monoclonal antibody
to rat IgE (Zymed, Camarillo, CA, U.S.A.) diluted 1/500 in
carbonate/bicarbonate buer. Plates were then blocked
with PBS-05% casein-01% Tween 20. Serum diluted 1/50
in PBS-05% casein-01% Tween 20 was added to the plates
followed by biotin-labeled OA or biotin-labeled BSA (1:50
dilution). The above steps were done at 2 h intervals at
378C. Between steps, plates were washed three times with
PBS-05% casein-01% Tween 20. Subsequently alkaline
phosphatase conjugated streptavidin in PBS-05% casein-
01% Tween 20 (1:500 dilution) was added for 30 min.
Plates were then developed at room temperature after
addition of the p-nitrophenyl phosphate disodium and read
with an ELISA plate reader (Model 400 ATC, SLT, Lab
Instruments, Pittsburgh, PA, U.S.A.) at 405 nm. Rat IgE
specific to OA and BSA are not commercially available so
that the results of specific immunoglobulin assays are
expressed in arbitrary units of absorbance. Plates were
developed to 20 and 10 absorbance units for OA and
BSA-specific IgE, respectively, for positive control samples
from either a OA- or a BSA-sensitized rat. Under these
conditions the values for negative controls were less than
001 units. There was no cross-reactivity between BSA and
OA for determination of specific IgE.
DATA ANALYSIS
For purposes of comparison among groups, RL was
expressed as a function of baseline RL. The ER was
calculated as the maximal value of RL within 30 min afterthe antigen challenge. A significant ER was defined as an
increase to at least 150% of baseline RL. The LR was
calculated as the area under the curve of RL versus time
from 150–480 min following antigen challenge. Compar-
isons among groups were done using one-way analysis of
variance and the Newman–Keuls test for multiple compar-
isons when data were normally distributed. When data were
not normally distributed, comparisons were made using a
non-parametric analysis of variance (Kruskal–Wallis)
followed by Fisher’s least significant dierence test.
Statistical significance was accepted at the 5% level of
confidence. Results are presented as meansstandard error
of the mean (SE).
Results
IMMUNOGLOBULIN DETERMINATION
In order to demonstrate successful sensitization to both
antigens, serum specific IgE levels were determined by
ELISA. Sensitization with both OA and BSA resulted in
production of specific OA-IgE (15920131 absorbance
units) and BSA-specific IgE (0318174 absorbance units),
confirming IgE responses to both allergens. Unfortunately
the levels of OA and BSA specific IgE could not be
compared because of the lack of availability of commer-
cially available standards.
AIRWAY RESPONSES TO LTD4
To confirm the development of OA-induced airway hyper-
responsiveness, we investigated the airway responses to
LTD4 in animals sensitized according to the current
protocol. Baseline RL values were similar between animals
previously exposed to saline and OA. As shown in Fig. 1,
airway responsiveness to LTD4 was significantly increased
in sensitized animals with exposure to OA 24 h earlier
compared to sensitized animals previously exposed to
saline.
EARLY AND LATE RESPONSES TO
ANTIGEN CHALLENGE
Baseline RL values were slightly higher in the animals
exposed to saline and previously exposed to OA compared
to other groups (OA-saline groups: 02660035 cm H2O
ml71 sec71 saline-BSA group: 0191+0039 cm H2O ml71
sec71 OA-BSA group: 0172+0042 cm H2O ml71 sec71
P5005). Figure 2 shows the mean percent of baseline RL
at each time point after the second antigen challenge. An
ER was observed in only one animal which was first
challenged with saline and subsequently with BSA (Fig. 3).
The maximal values of RL (percent of baseline value) within
the 30 min following the antigen challenge were
1181+96%, 1265+91% and 1077+86% for the OA-
saline, the saline-BSA and the OA-BSA groups, respectively
(Pn.s.).
FIG 1. Changes in lung resistance induced by tracheal
instillation of increasing doses of LTD4 in sensitized BN
rats 24 h after saline (open circles) or OA (closed circles)
exposure. Values are meansSEM. *P5005. –*–: saline
(n4); –*–: OVA (n7).
FIG 2. Time course of changes in lung resistance (RL) after antigen challenge. Rats were sensitized to OA and BSA on day 0.
On day 14 rats were exposed to either aerosolized OA or saline and were then challenged with BSA or saline 24 h later
according to the study group. Rats were analysed for changes in RL before, at 5, 10 and 15 min after the second antigen, and
at 15-min intervals for a total period of 8 h. Mean (SE) values are shown for rats from the OA-saline (open triangles),
saline-BSA (open circles) and OA-BSA (closed circles) groups. –!–: OA-saline; –*–: saline-BSA; –*–: OA-BSA.
FIG 3. Early allergic responses, expressed as a percentage
of baseline, to inhaled BSA in rats preexposed to either
saline (open circles, n=9) or OA (closed circles, n=10)
and ER to inhaled saline in rats previously exposed to OA
(open triangles, n=8). Individual data points are shown
along with group mean values (horizontal lines).
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FIG 4. Late allergic responses (LR) to inhaled BSA in rats
preexposed to either saline (open circles n=9) or OA
(closed circles, n=10) and LR to inhaled saline in rats
previously exposed to OA (open triangles, n=8).
Individual data points are shown along with group mean
values (horizontal lines). LRs were significantly greater in
animals exposed to BSA compared to saline * P5005.
48 S. LABERGE ET AL.The LR as measured by the area under the RL vs time
curve (Fig. 4) were significantly increased in the animals
challenged with BSA (1516+386) compared to saline
(376+409; P5005). However previous exposure to OAFIG 5. Dierential cell counts from bronchoalveolar lavage flui
shown. Eosinophils were increased in the OA-saline and OA-B
Lymphocytes were increased in the OA-BSA group versus the sa
the OA-BSA group compared to the saline-BSA group (*P50
BSA (n=10).did not further increase the LR in animals subsequently
challenged with BSA (2011+367).
BRONCHOALVEOLAR LAVAGE
The total leukocyte counts and the absolute neutrophil
counts did not dier among the three groups (Fig. 5). Total
numbers of macrophages were significantly increased in the
animals challenged with both OA and BSA
(1816106+021) compared to the numbers retrieved from
the animals challenged with OA and saline
(0996106+022; P5005). Total numbers of eosinophils
and lymphocytes were significantly increased following
BSA challenge in previously OA-challenged animals
(0986106+023 and 0246106+004, respectively) com-
pared to numbers retrieved from animals previously
exposed to saline (0096106+020 and 0106106+004,
respectively; P5005).
Discussion
The results of this study show that the exposure of the rat to
an antigen to which it has been previously sensitized does
not significantly modify the pattern of bronchoconstriction
that follows the administration of a second distinct antigen.
Nonetheless the profile of inflammatory cells recovered
from the bronchoalveolar lavage is substantially altered;
eosinophils and lymphocytes are present in increased
numbers in animals with previous exposure to ovalbumin.
Furthermore, previous exposure to OA is associated with
increased reactivity to LTD4, a mediator known to bed 8 h after BSA challenge. Group mean data (SE) are
SA groups versus the saline-BSA group (**P5005).
line-BSA group (*P5005). Macrophages were increased in
05). &: OA-saline (n=8), : saline-BSA (n=10); : OA-
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Norway (BN) rats (22,23). However, the presence of an
intense inflammatory cell infiltrate and airway hyperrespon-
siveness at the time of the second challenge does not
amplify the airway responses to this antigen.
In the present study, antigen challenge was associated
with only few early responses. The early allergic response to
antigen results predominantly from the interaction between
IgE and mast cells with subsequent mast cell degranulation
and release of the biogenic amines histamine or serotonin
and cysteinyl–leukotrienes which are responsible for the
acute phase of airway obstruction (24). The presence of
antigen-specific IgE is mandatory for the development of
this acute response although there is no direct relationship
between the serum levels of specific IgE and the magnitude
of the ER (21). In the present study, sensitization resulted in
production of serum specific IgE to both of the antigens
administered. Despite the presence of BSA-specific IgE, an
early allergic response was observed only in one animal
following BSA challenge. These results contrast with
previous experiments in which OA challenge elicited an
early response in approximately 70% of the animals (16).
These results indicate that the presence of IgE although a
necessary condition for the development of early responses
other modulating factors appear to be involved.
Another potential important issue is the sensitization
protocol used in the present study. Despite production of
significant levels of specific IgE we cannot exclude the
possibility that administration of both antigens at the same
moment during the sensitization protocol might have
aected other immunoglobulin isotypes such as IgG. In a
previous study from our laboratory an inverse relationship
was found between the levels of allergen-specific IgG and
the magnitude of the early response following challenge
(21). However, we do not have any data on the levels of
specific IgG to BSA. Finally, other factors such as the
nature of the antigen, repeated anesthesia, interval between
the challenges may be important factors in the modulation
of airway responses to antigen in the present protocol.
Despite the near absence of early allergic responses,
significant late allergic responses were identified in the vast
majority of animals following BSA challenge. The occur-
rence of late responses in these animals indicates successful
sensitization to BSA using the present protocol and is
consistent with activation of the immune eector cells
within the airways in response to antigen challenge. Recent
evidence shows that early and late responses can in certain
circumstances be clearly dissociated. Late responses can be
transferred by CD4 T cells in the rat in the absence of any
demonstrable IgE and early responses (25). Isolated late
responses are also well described after allergen challenge in
human subjects (3,26). Although the mechanisms involved
in the pathogenesis of the late allergic response are still
incompletely elucidated airway inflammation appears to be
a cardinal feature of LR both in animal models and in
humans (27) In particular, activated eosinophils and
lymphocytes are thought to play an important role in the
physiological response to allergens through the release of
cationic proteins and cytokines (28). We therefore reasoned
that OA-induced airway inflammation and associatedincrease in airway eosinophil numbers would further
increase the airway responses to a second antigen.
The increase in eosinophil numbers in the bronchoalveo-
lar lavage following the second allergen is consistent with
the previous observation of eosinophilia 24–32 h after
ovalbumin challenge (18,19). Despite the substantial
eosinophilia, the only apparent modification of the LAR
was an earlier onset. However, the overall magnitude of the
LRs did not dier significantly between groups. These data
suggest that increased numbers of inflammatory cells, in
particular eosinophils and lymphocytes, are not sucient to
enhance development of late allergic response to a
subsequent antigen challenge. Furthermore the magnitude
of the LR did not correlate to the numbers of neutrophils,
eosinophils or lymphocytes retrieved from the bronchoal-
veolar lavage. Even in those animals which had the largest
LR after OA and BSA challenge there were no distinguish-
ing features in terms of IgE or inflammatory cell responses
to sensitization and challenge.
We and others have shown that significant increase in
responsiveness to methacholine occurs 24–32 h after OA
challenge in BN rats (18,19). The present results also show
that airways of rats previously exposed to OA exhibit
greater responses to LTD4. These findings suggest that
previous exposure to an antigen is associated with enhanced
airway responses to mediators of the late response. Despite
development of airway hyper-responsiveness to LTD4 we
were surprised that the late allergic response to BSA was
not enhanced in rats previously exposed to OA. These
findings indicate that previous exposure to an antigen may
have induced some form of immune tolerance or relative
depletion of allergic mediators even though animals were
exposed to two unrelated antigens.
In summary, we have shown that previous exposure to
OA did not further increase the LR to BSA challenge
despite substantial increases in inflammatory cells in the
airways in a rat model of allergen-induced airway
bronchoconstriction and inflammation. Perhaps chronic
exposure to allergen is required for induction of airway
changes that would lead to augmentation of airway
responses to allergen challenge.
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